These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2434682)

  • 21. Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes.
    Zou LY; Hao XM; Zhang GQ; Zhang M; Guo JH; Liu TF
    Can J Physiol Pharmacol; 2001 Jul; 79(7):621-6. PubMed ID: 11478596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.
    Sanguinetti MC; Kass RS
    Circ Res; 1984 Sep; 55(3):336-48. PubMed ID: 6088117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
    Chahine M; Sculptoreanu A; Varma DR
    Can J Physiol Pharmacol; 2003 Feb; 81(2):135-41. PubMed ID: 12710527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open and inactivated sodium channel block by class-I antiarrhythmic drugs.
    Kodama I; Toyama J; Yamada K
    Jpn Heart J; 1986 Nov; 27 Suppl 1():83-9. PubMed ID: 2434686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.
    Cerbai E; Giotti A; Mugelli A
    Br J Pharmacol; 1997 Feb; 120(4):667-75. PubMed ID: 9051306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of dihydropyridine-sensitive Ca++ channels by ethanol in undifferentiated and nerve growth factor-treated PC12 cells: interaction with the inactivated state.
    Mullikin-Kilpatrick D; Treistman SN
    J Pharmacol Exp Ther; 1995 Feb; 272(2):489-97. PubMed ID: 7853161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of agmatine on L-type calcium current in rat ventricular myocytes.
    Li Q; Yin JX; He RR
    Acta Pharmacol Sin; 2002 Mar; 23(3):219-24. PubMed ID: 11918845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and Gbetagamma modulation of Ca(v)2.2 channels with different auxiliary beta subunits.
    Meir A; Dolphin AC
    Pflugers Arch; 2002 May; 444(1-2):263-75. PubMed ID: 11976940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.
    Williams JS; Grupp IL; Grupp G; Vaghy PL; Dumont L; Schwartz A; Yatani A; Hamilton S; Brown AM
    Biochem Biophys Res Commun; 1985 Aug; 131(1):13-21. PubMed ID: 2412552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydropyridine chirality at the chromaffin cell calcium channel.
    Fonteriz RI; Gandia L; Lopez MG; Artalejo CR; García AG
    Brain Res; 1987 Apr; 408(1-2):359-62. PubMed ID: 2439171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of L-type Ca2+ channels in portal vein myocytes by the enantiomers of oxodipine.
    Baron A; Rakotoarisoa L; Leprêtre N; Mironneau J
    Eur J Pharmacol; 1994 Sep; 269(1):105-13. PubMed ID: 7828652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels.
    Uneyama H; Uchida H; Konda T; Yoshimoto R; Akaike N
    Eur J Pharmacol; 1999 May; 373(1):93-100. PubMed ID: 10408255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channels in the heart. Properties and modulation by dihydropyridine enantiomers.
    Reuter H; Porzig H; Kokubun S; Prod'hom B
    Ann N Y Acad Sci; 1988; 522():16-24. PubMed ID: 2454050
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.
    Hondeghem LM; Katzung BG
    Annu Rev Pharmacol Toxicol; 1984; 24():387-423. PubMed ID: 6203481
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcium channel agonist and antagonist effects of the stereoisomers of the dihydropyridine 202-791.
    Kongsamut S; Kamp TJ; Miller RJ; Sanguinetti MC
    Biochem Biophys Res Commun; 1985 Jul; 130(1):141-8. PubMed ID: 2411259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells.
    Cataldi M; Taglialatela M; Palagiano F; Secondo A; de Caprariis P; Amoroso S; di Renzo G; Annunziato L
    Eur J Pharmacol; 1999 Jul; 376(1-2):169-78. PubMed ID: 10440102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ionic channels underlying the ventricular action potential in zebrafish embryo.
    Alday A; Alonso H; Gallego M; Urrutia J; Letamendia A; Callol C; Casis O
    Pharmacol Res; 2014 Jun; 84():26-31. PubMed ID: 24747832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine.
    Hof RP; Rüegg UT; Hof A; Vogel A
    J Cardiovasc Pharmacol; 1985; 7(4):689-93. PubMed ID: 2410709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.